Myeloprotection with Trilaciclib in Chinese Patients with Extensive-Stage Small Cell Lung Cancer Receiving Standard Chemotherapy (TRACES) | |
Cheng, Y.2; Wu, L.3; Huang, D. Z.4; Wang, Q. M.5; Fan, Y.6; Liu, Z. F.7; Fan, H. J.8; Yao, W. X.9; Liu, B. G.10; Yu, G. H.11 | |
刊名 | JOURNAL OF THORACIC ONCOLOGY |
2022-09-01 | |
卷号 | 17 |
关键词 | Trilaciclib SCLC Myelopreservation |
ISSN号 | 1556-0864 |
WOS研究方向 | Oncology ; Respiratory System |
语种 | 英语 |
出版者 | ELSEVIER SCIENCE INC |
WOS记录号 | WOS:000858678101207 |
内容类型 | 期刊论文 |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/129777] |
专题 | 中国科学院合肥物质科学研究院 |
作者单位 | 1.Guangdong Med Univ, Affiliated Hosp, Zhanjiang, Peoples R China 2.Jilin Canc Hosp, Changchun, Peoples R China 3.Cent South Univ, Hunan Canc Hosp, Xiangya Sch Med, Affiliated Canc Hosp, Changsha, Peoples R China 4.Tianjin Med Univ, Canc Hosp & Inst, Tianjin, Peoples R China 5.Henan Canc Hosp, Zhengzhou, Peoples R China 6.Univ Chinese Acad Sci, Zhejiang Canc Hos, Canc Hosp, Hangzhou, Peoples R China 7.Shandong Canc Hosp & Inst, Shandong, Peoples R China 8.Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China 9.Sichuan Canc Hosp, Sichuan, Peoples R China 10.Harbin Med Univ, Canc Hosp, Harbin, Peoples R China |
推荐引用方式 GB/T 7714 | Cheng, Y.,Wu, L.,Huang, D. Z.,et al. Myeloprotection with Trilaciclib in Chinese Patients with Extensive-Stage Small Cell Lung Cancer Receiving Standard Chemotherapy (TRACES)[J]. JOURNAL OF THORACIC ONCOLOGY,2022,17. |
APA | Cheng, Y..,Wu, L..,Huang, D. Z..,Wang, Q. M..,Fan, Y..,...&Sun, S. G..(2022).Myeloprotection with Trilaciclib in Chinese Patients with Extensive-Stage Small Cell Lung Cancer Receiving Standard Chemotherapy (TRACES).JOURNAL OF THORACIC ONCOLOGY,17. |
MLA | Cheng, Y.,et al."Myeloprotection with Trilaciclib in Chinese Patients with Extensive-Stage Small Cell Lung Cancer Receiving Standard Chemotherapy (TRACES)".JOURNAL OF THORACIC ONCOLOGY 17(2022). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论